This section of the website is for patients who have been prescribed IQIRVO® (elafibranor) in the UK. Information for members of the general public can be found here.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

Understanding primary biliary cholangitis (PBC) to support someone living with PBC

Primary Biliary Cholangitis (PBC) File
6 pages

This resource is designed to help you better understand PBC, how it might make someone feel, and how you can support someone living with PBC.

This material is intended to be viewed online

ELA-UK-000183 | November 2024

Understanding primary  biliary cholangitis (PBC) to support someone living with PBC
Explore more Primary Biliary Cholangitis (PBC) Patient Support

Explore more Primary Biliary Cholangitis (PBC) Patient Support

Browse